170 related articles for article (PubMed ID: 29238589)
1. Cannabidiol restores intestinal barrier dysfunction and inhibits the apoptotic process induced by
Gigli S; Seguella L; Pesce M; Bruzzese E; D'Alessandro A; Cuomo R; Steardo L; Sarnelli G; Esposito G
United European Gastroenterol J; 2017 Dec; 5(8):1108-1115. PubMed ID: 29238589
[TBL] [Abstract][Full Text] [Related]
2. Lathyrus sativus diamine oxidase reduces Clostridium difficile toxin A-induced toxicity in Caco-2 cells by rescuing RhoA-GTPase and inhibiting pp38-MAPK/NF-κB/HIF-1α activation.
Pietrangeli P; Corpetti C; Seguella L; Del Re A; Pesce M; Vincenzi M; Lori C; Annunziata G; Mateescu MA; Sarnelli G; Esposito G; Marcocci L
Phytother Res; 2021 Jan; 35(1):415-423. PubMed ID: 32914548
[TBL] [Abstract][Full Text] [Related]
3. Clostridium difficile toxins may augment bacterial penetration of intestinal epithelium.
Feltis BA; Kim AS; Kinneberg KM; Lyerly DL; Wilkins TD; Erlandsen SL; Wells CL
Arch Surg; 1999 Nov; 134(11):1235-41; discussion 1241-2. PubMed ID: 10555639
[TBL] [Abstract][Full Text] [Related]
4. Rifaximin Improves Clostridium difficile Toxin A-Induced Toxicity in Caco-2 Cells by the PXR-Dependent TLR4/MyD88/NF-κB Pathway.
Esposito G; Nobile N; Gigli S; Seguella L; Pesce M; d'Alessandro A; Bruzzese E; Capoccia E; Steardo L; Cuomo R; Sarnelli G
Front Pharmacol; 2016; 7():120. PubMed ID: 27242527
[TBL] [Abstract][Full Text] [Related]
5. Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa.
Castagliuolo I; Riegler MF; Valenick L; LaMont JT; Pothoulakis C
Infect Immun; 1999 Jan; 67(1):302-7. PubMed ID: 9864230
[TBL] [Abstract][Full Text] [Related]
6. Translocation of Clostridium difficile toxin B across polarized Caco-2 cell monolayers is enhanced by toxin A.
Du T; Alfa MJ
Can J Infect Dis; 2004 Mar; 15(2):83-8. PubMed ID: 18159481
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of Clostridium difficile toxin-induced damage to epithelial barrier by ecto-5'-nucleotidase (CD73) and adenosine receptor signaling.
Schenck LP; Hirota SA; Hirota CL; Boasquevisque P; Tulk SE; Li Y; Wadhwani A; Doktorchik CT; Macnaughton WK; Beck PL; MacDonald JA
Neurogastroenterol Motil; 2013 Jun; 25(6):e441-53. PubMed ID: 23600886
[TBL] [Abstract][Full Text] [Related]
8. The P2Y6 receptor mediates Clostridium difficile toxin-induced CXCL8/IL-8 production and intestinal epithelial barrier dysfunction.
Hansen A; Alston L; Tulk SE; Schenck LP; Grassie ME; Alhassan BF; Veermalla AT; Al-Bashir S; Gendron FP; Altier C; MacDonald JA; Beck PL; Hirota SA
PLoS One; 2013; 8(11):e81491. PubMed ID: 24278446
[TBL] [Abstract][Full Text] [Related]
9. Delta-toxin from Clostridium perfringens perturbs intestinal epithelial barrier function in Caco-2 cell monolayers.
Seike S; Takehara M; Takagishi T; Miyamoto K; Kobayashi K; Nagahama M
Biochim Biophys Acta Biomembr; 2018 Feb; 1860(2):428-433. PubMed ID: 28988777
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-inducible factor signaling provides protection in Clostridium difficile-induced intestinal injury.
Hirota SA; Fines K; Ng J; Traboulsi D; Lee J; Ihara E; Li Y; Willmore WG; Chung D; Scully MM; Louie T; Medlicott S; Lejeune M; Chadee K; Armstrong G; Colgan SP; Muruve DA; MacDonald JA; Beck PL
Gastroenterology; 2010 Jul; 139(1):259-69.e3. PubMed ID: 20347817
[TBL] [Abstract][Full Text] [Related]
11. Protective role of HSP72 against Clostridium difficile toxin A-induced intestinal epithelial cell dysfunction.
Liu TS; Musch MW; Sugi K; Walsh-Reitz MM; Ropeleski MJ; Hendrickson BA; Pothoulakis C; Lamont JT; Chang EB
Am J Physiol Cell Physiol; 2003 Apr; 284(4):C1073-82. PubMed ID: 12490434
[TBL] [Abstract][Full Text] [Related]
12. Human alpha-defensins inhibit Clostridium difficile toxin B.
Giesemann T; Guttenberg G; Aktories K
Gastroenterology; 2008 Jun; 134(7):2049-58. PubMed ID: 18435932
[TBL] [Abstract][Full Text] [Related]
13. Essential role of toxin A in C. difficile 027 and reference strain supernatant-mediated disruption of Caco-2 intestinal epithelial barrier function.
Sutton PA; Li S; Webb J; Solomon K; Brazier J; Mahida YR
Clin Exp Immunol; 2008 Sep; 153(3):439-47. PubMed ID: 18505424
[TBL] [Abstract][Full Text] [Related]
14. The American Cockroach Peptide Periplanetasin-2 Blocks
Hong J; Zhang P; Yoon IN; Hwang JS; Kang JK; Kim H
J Microbiol Biotechnol; 2017 Apr; 27(4):694-700. PubMed ID: 28173695
[No Abstract] [Full Text] [Related]
15. Protein kinase C signaling regulates ZO-1 translocation and increased paracellular flux of T84 colonocytes exposed to Clostridium difficile toxin A.
Chen ML; Pothoulakis C; LaMont JT
J Biol Chem; 2002 Feb; 277(6):4247-54. PubMed ID: 11729192
[TBL] [Abstract][Full Text] [Related]
16. Bile salt inhibition of host cell damage by Clostridium difficile toxins.
Darkoh C; Brown EL; Kaplan HB; DuPont HL
PLoS One; 2013; 8(11):e79631. PubMed ID: 24244530
[TBL] [Abstract][Full Text] [Related]
17. A Palmitoylethanolamide Producing
Esposito G; Corpetti C; Pesce M; Seguella L; Annunziata G; Del Re A; Vincenzi M; Lattanzi R; Lu J; Sanseverino W; Sarnelli G
Front Pharmacol; 2021; 12():639728. PubMed ID: 33986673
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological effects of cannabinoids on the Caco-2 cell culture model of intestinal permeability.
Alhamoruni A; Lee AC; Wright KL; Larvin M; O'Sullivan SE
J Pharmacol Exp Ther; 2010 Oct; 335(1):92-102. PubMed ID: 20592049
[TBL] [Abstract][Full Text] [Related]
19. Cannabidiol Isolated From
Cocetta V; Governa P; Borgonetti V; Tinazzi M; Peron G; Catanzaro D; Berretta M; Biagi M; Manetti F; Dall'Acqua S; Montopoli M
Front Pharmacol; 2021; 12():641210. PubMed ID: 33995048
[TBL] [Abstract][Full Text] [Related]
20. Clostridium difficile toxins A and B can alter epithelial permeability and promote bacterial paracellular migration through HT-29 enterocytes.
Feltis BA; Wiesner SM; Kim AS; Erlandsen SL; Lyerly DL; Wilkins TD; Wells CL
Shock; 2000 Dec; 14(6):629-34. PubMed ID: 11131913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
